Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding ResMed is 'Buy'. Macroaxis provides ResMed buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ResMed positions. The advice algorithm takes into account all of ResMed available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from ResMed buy-and-hold prospective. Additionally take a look at ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus.
ResMed Current RecommendationFor the selected time horizon ResMed has a risk adjusted performance of 0.01, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.2637 and treynor ratio of 0.0Macroaxis provides advice on ResMed to complement and cross-verify current analyst consensus on ResMed. Our recommendation engine determines the corporation potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure ResMed is not overpriced, please check all ResMed fundamentals including its Book Value Per Share, Retained Earnings and the relationship between Cash per Share and Number of Employees . Given that ResMed has Price to Earning of 53.87 times, we recommend you check out ResMed market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.
ResMed Thematic Classifications
Returns Distribution Density
ResMed Volatility Alert
|Better Than Average||Worse Than Average||Compare ResMed to competition|